Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
UK NEQAS webinar: Introduction to Immunocytochemistry
Online
14-15 July, 2026
UK NEQAS webinar: Introduction to Direct Immunofluorescence
Online
16 July, 2026
IHC Antibody Recognition & Expression Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
4 August, 2026
IHC Technical Issues Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 August, 2026
ECP 2026 - 38th European Congress of Pathology
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026